Readers of the article will have noted this para:Giving Fletcher access to the unapproved drug was “quite a rigorous process”, said Recce chief executive James Graham.
But eventually, an independent medical committee decided that the antibiotic could be given to Fletcher, since it has been approved for use on burn victims as part of a phase 1/2 clinical trial at the Fiona Stanley burns unit in Perth.
Graham said as far as he knew there had been no burns victims treated with the Recce 327 yet, which would make Fletcher the first human formally treated with the antibiotic. It was possible scientists tested it on themselves informally, he added.
Geez, I'm astonished...after all I'm hanging around the house day after day waiting on those "imminent" burns results; or have I got it wrong? What do people think?
Ann: Positive Sinusitis Patient Update - Special Access Scheme, page-126
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
29.5¢ |
Change
0.005(1.72%) |
Mkt cap ! $83.62M | |||
| Open | High | Low | Value | Volume |
| 29.0¢ | 32.0¢ | 29.0¢ | $25.51K | 83.93K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 8308 | 29.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 30.5¢ | 7696 | 4 |
View Market Depth
| Last trade - 14.16pm 25/06/2025 (20 minute delay) ? |
| RCE (ASX) Chart |